image description

Tag: Teodora Staeva

Lupus Accelerating Breakthroughs Consortium Announces Expanded Partnership with U.S. FDA at First Anniversary Meeting

BETHESDA, MD, April 16, 2024 — The Lupus Research Alliance (LRA), founder and administrator of the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), announced today at the Consortium’s first anniversary meeting an expanded partnership with the U.S. Food and Drug Administration (FDA) with the inclusion of the Center for Biologics Evaluation and Research (CBER). The addition […] Read More

LRA Announces Partners on the First Anniversary of the Lupus Landmark Study

April 11, 2024 The Lupus Research Alliance (LRA) and its clinical research affiliate Lupus Therapeutics (LT) are pleased to announce the group of industry partners working together on the implementation of the Lupus Nexus. The Lupus Nexus, one of LRA’s most ambitious and groundbreaking endeavors, is a first-of-its-kind lupus registry, biorepository, and data exchange platform […] Read More

Lupus Research Alliance and its Clinical Research Affiliate Lupus Therapeutics Launch the Lupus Landmark Study to Accelerate Personalized Treatments in Lupus

NEW YORK, NY. May 23, 2023 – The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics launched the Lupus Landmark Study, a groundbreaking observational research study to accelerate the development of personalized treatments for people living with lupus. As the largest study of its kind in lupus, the Lupus Landmark Studywill follow 3,500 adults […] Read More

Lupus Research Alliance Unites the U.S. Food & Drug Administration (FDA) & Lupus Community to Launch Novel Public-Private Partnership

Lupus Accelerating Breakthroughs Consortium to address challenges impacting lupus trial success and to accelerate treatment breakthroughs  WASHINGTON, DC, March 29, 2023 – The Lupus Research Alliance (LRA) today announced the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), a first-of-its-kind public-private partnership bringing people with lupus together in collaboration with the U.S. Food and Drug Administration (FDA), […] Read More

CAR T Cell Therapy Induces Lupus Remission in Small Study

September 21, 2022 Results of a small study published in the prestigious journal Nature Medicine, suggest that a type of immune cell therapy called chimeric antigen receptor (CAR) T cell therapy could become a highly effective therapy for SLE patients who do not respond to current lupus treatments.  CD19 CAR T cells are T cells that […] Read More

Lupus Research Alliance Launches Two Major Initiatives to Increase Participation of Underrepresented Minorities in Lupus Clinical Trials and Research

NEW YORK, NY. January 27 — The Lupus Research Alliance (LRA) and clinical affiliate Lupus Therapeutics (LT) announced two major initiatives improving  representation of minorities in clinical trials and  the scientific research profession: Project CHANGE by LT and the Diversity in Lupus Research Program. The LRA has been addressing these disparities for many years and now proudly launches this […] Read More

Pivotal LRA-Funded Research Shared at Annual Rheumatology Meeting

November 15, 2021 The Lupus Research Alliance (LRA) supports research into causes and mechanisms of lupus, and identification of targets supporting the development of new therapies or cures for lupus patients. At this year’s meeting of the American College of Rheumatology (ACR), 17 LRA-funded researchers presented their work to share discoveries with the thousands of […] Read More

LRA’s Virtual Annual Conference Brings Together Top Lupus Researchers for Dynamic Scientific Exchange

October 28, 2021 Two-day meeting focuses on sharing latest news and generating new scientific ideas  The Lupus Research Alliance (LRA) held our annual scientific conference, the Forum for Discovery, online for a second year given the continued concerns during the COVID-19 pandemic. The virtual capability allowed more than 150 funded investigators, scientific advisors, and partners […] Read More